These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 2969950

  • 21. Dopamine D1 and D2 receptor selectivities of agonists and antagonists.
    Seeman P, Ulpian C.
    Adv Exp Med Biol; 1988; 235():55-63. PubMed ID: 2976254
    [Abstract] [Full Text] [Related]

  • 22. Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat.
    Andersson K, Fuxe K, Eneroth P, Härfstrand A, Agnati LF.
    Neuroendocrinology; 1988 Aug; 48(2):188-200. PubMed ID: 2975769
    [Abstract] [Full Text] [Related]

  • 23. Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors.
    Dubois A, Savasta M, Curet O, Scatton B.
    Neuroscience; 1986 Sep; 19(1):125-37. PubMed ID: 2946980
    [Abstract] [Full Text] [Related]

  • 24. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain.
    Boyson SJ, McGonigle P, Molinoff PB.
    J Neurosci; 1986 Nov; 6(11):3177-88. PubMed ID: 3534157
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression.
    Sumiyoshi T, Stockmeier CA, Overholser JC, Thompson PA, Meltzer HY.
    Brain Res; 1995 May 29; 681(1-2):109-16. PubMed ID: 7552267
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes.
    Hall H, Wedel I, Halldin C, Kopp J, Farde L.
    J Neurochem; 1990 Dec 29; 55(6):2048-57. PubMed ID: 1977888
    [Abstract] [Full Text] [Related]

  • 30. Binding of [3H]SCH 39166 to human post mortem brain tissue.
    Hall H, Halldin C, Sedvall G.
    Pharmacol Toxicol; 1993 Mar 29; 72(3):152-8. PubMed ID: 8516265
    [Abstract] [Full Text] [Related]

  • 31. Chronic haloperidol alters dopamine receptors: effects of cocaine exposure during the preweaning period.
    Shi X, Yin R, Dow-Edwards D.
    Eur J Pharmacol; 1999 Apr 16; 370(3):241-9. PubMed ID: 10334498
    [Abstract] [Full Text] [Related]

  • 32. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P, Lesourd M, Comoy E.
    Eur J Pharmacol; 1998 Jul 10; 352(2-3):179-87. PubMed ID: 9716353
    [Abstract] [Full Text] [Related]

  • 33. Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain.
    Wamsley JK, Gehlert DR, Filloux FM, Dawson TM.
    J Chem Neuroanat; 1989 Jul 10; 2(3):119-37. PubMed ID: 2528968
    [Abstract] [Full Text] [Related]

  • 34. Subtypes of dopamine receptors involved in the mechanism of reinforcement.
    Nakajima S.
    Neurosci Biobehav Rev; 1989 Jul 10; 13(2-3):123-8. PubMed ID: 2530477
    [Abstract] [Full Text] [Related]

  • 35. Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.
    Lublin H, Gerlach J, Peacock L.
    Psychopharmacology (Berl); 1993 Jul 10; 112(2-3):389-97. PubMed ID: 7871047
    [Abstract] [Full Text] [Related]

  • 36. Autoradiographic localization of D1 and D2 dopamine receptors in the human brain.
    De Keyser J, Claeys A, De Backer JP, Ebinger G, Roels F, Vauquelin G.
    Neurosci Lett; 1988 Aug 31; 91(2):142-7. PubMed ID: 2972942
    [Abstract] [Full Text] [Related]

  • 37. Imaging dopamine D4 receptors in the living primate brain: a positron emission tomography study using the novel D1/D4 antagonist [11C]SDZ GLC 756.
    Boy C, Klimke A, Holschbach M, Herzog H, Mühlensiepen H, Rota Kops E, Sonnenberg F, Gaebel W, Stöcklin G, Markstein R, Müller-Gärtner HW.
    Synapse; 1998 Dec 31; 30(4):341-50. PubMed ID: 9826226
    [Abstract] [Full Text] [Related]

  • 38. Characterization of D1 dopamine receptors in the bovine pineal gland with [3H]SCH 23390.
    Simonneaux V, Murrin LC, Ebadi M.
    J Pharmacol Exp Ther; 1990 Apr 31; 253(1):214-20. PubMed ID: 2139469
    [Abstract] [Full Text] [Related]

  • 39. Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells.
    Schoors DF, Vauquelin GP, De Vos H, Smets G, Velkeniers B, Vanhaelst L, Dupont AG.
    Br J Pharmacol; 1991 Aug 31; 103(4):1928-34. PubMed ID: 1833020
    [Abstract] [Full Text] [Related]

  • 40. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
    Protais P, Chagraoui A, Arbaoui J, Mocaër E.
    Eur J Pharmacol; 1994 Dec 12; 271(1):167-77. PubMed ID: 7698199
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.